Upper Respiratory Tract Infections
48
2
3
35
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.4%
5 terminated out of 48 trials
87.5%
+1.0% vs benchmark
15%
7 trials in Phase 3/4
23%
8 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (48)
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)
Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Study of the Preventive Effects and Mechanisms of Yeast β-Glucan on Upper Respiratory Tract Infections
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
Effect of Over-the-counter NSAIDS on Cough Reflex Sensitivity in Patients with Upper Respiratory Tract Infections
Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections
Edinburgh and Lothian Virus Intervention Study in Kids
Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections
Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care
Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections
A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers
Reducing Unnecessary Antibiotic Prescriptions in Primary Healthcare in Saskatchewan by Identifying High Prescribers
COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).